Taris
Pioneering the field of drug-device convergence for targeted therapies.
About Us: Investors
Flagship Ventures
Founded in 2000, Flagship manages over $600 million in early-stage funds. With an active portfolio of over 40 companies, the firm’s strategy is to balance its investments across three principal business sectors: Therapeutics, Life Science Tools & Diagnostics, and BioEnergy/Cleantech.
Flybridge Capital Partners
Flybridge Capital Partners is an early-stage venture capital firm with $560 million under management. The firm is focused on investing in consumer, energy, healthcare and information technology markets and is led by a team with domain expertise and more than half a century of combined experience in venture capital.
Polaris Venture Partners
Polaris invests in promising early stage information technology and life science businesses to help them grow into sustainable, market-leading companies. In addition, Polaris is committed to providing growth equity and shareholder liquidity to established companies in the technology, healthcare, manufacturing, media, communications, and business services sectors. The firm has over $3 billion under management, more than 20 investment professionals, and current investments in more than 115 companies.
